Health has become a top issue for Apple. And it seems very successful to me. We are increasingly witnessing new studies by the company to see how its devices can help people's health.
Today has come to light the beginning of a new American study by Apple in collaboration with Johnson & Johnson of how the Apple Watch and the iPhone can help collect very important data for the study and prevention of vascular diseases like cerebral stroke. Bravo for the two companies.
Apple and Johnson & Johnson today announced the start of a new study called "Heartline Study" that aims to collect more information on atrial fibrillation and the like with Apple devices: iPhone and Apple Watch.
This study is based on an application for such devices that will study the collected follow-up cardiac data to see if it can increase alerts to potential vascular complications such as cerebral stroke.
It will be based on collecting data from users over 65 years of age. Apple and Johnson & Johnson want to study the data collected by the Apple Watch, to see if such information can help reduce the risk of stroke thanks to the early detection of atrial fibrillation, detectable thanks to the ECG of the Apple watch.
The main problem with atrial fibrillation is that it has no obvious symptoms in the sufferer, so it is very difficult to diagnose. Thanks to the Apple Watch, the user can be alerted that they are suffering from an atrial fibrillation crisis even if the person does not notice it.
People interested in participating in the study must be 65 years or older and residents of the United States. They must have traditional Medicare, own an iPhone 6s or later, and agree to provide their health data to the study. After a selection process, two groups will be created: one group will use only one application on their mobile, and participants from the other group will be provided with an Apple Watch for data collection. The study will last three years.